S. 775 · 118th Congress (2023–2025)
Increasing Transparency in Generic Drug Applications Act
This bill requires the Food and Drug Administration (FDA) to inform generic drug applicants, upon request or during review, whether the drug is qualitatively and quantitatively the same as the listed brand-name drug (and if not, the reasons why). The FDA must also update or publish guidance on how it makes such determinations.
Show official title
A bill to provide for increased transparency in generic drug applications.
Expired in Senate committee
Derived from the legislative history, not an official disposition.
Latest actionReferred to committee
This bill’s path
This is S. 775’s recorded path, not a universal congressional workflow.
How bills become lawAll actionsIntroduced
Passed Senate
Passed House
Sent to President
Signed into law
Expired
- Sponsor
- Sen. Margaret Wood Hassan (D-NH)
- Cosponsors
3 cosponsors
1 original · 2 later
- Sen. Rand Paul (R-KY)· Original · Mar 14, 2023
- Sen. Mike Braun (R-IN)· Later · Mar 28, 2023
- Sen. John W. Hickenlooper (D-CO)· Later · Apr 25, 2023
- Policy area
- Health
- Subjects
- Administrative law and regulatory procedures
- Department of Health and Human Services
- Drug safety, medical device, and laboratory regulation
- Prescription drugs
On this page
Timeline
i
In chronological order. Major procedural acts are shown in full. Committee work and ordinary amendments fold in place where they happened, so they do not jump the sequence or stretch the timeline.
Introduced in Senate
Document: Introduced in Senate
Sources
- Congress.gov action
- Library of Congress
- Latest
Referred to committee
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Sources
- Congress.gov action
- Senate
Expired
Introduced → Referred to Senate Health, Education, Labor, and Pensions → No further action before the 118th Congress ended.
Committees
Text & titles
i
Each distinct name Congress.gov recorded, once. Official, short, display, and popular titles stay distinct when the wording differs. The same wording is not repeated for every text version.
| Version | Date | Links |
|---|---|---|
| Introduced in Senate |
Titles (2)
Increasing Transparency in Generic Drug Applications Act
Display title, Short title · Introduced in Senate
A bill to provide for increased transparency in generic drug applications.
Official title · Introduced in Senate